Clinical trials have focused on lipid-lowering medications' effects on subclinical cardiovascular disease as well as the role of hormone therapy, diet and vitamin supplements on heart disease, cancer and osteoporosis in postmenopausal women.
Jean Wactawski-Wende, PhD, principal investigator of UB’s Women’s Health Initiative (WHI) Center, discusses the significance of the WHI, one of the longest and most comprehensive studies ever done on postmenopausal women.